Pregnant women face tough choices about medication use due to lack of safety data − here’s why medical research cuts will make it worse
- Written by Almut Winterstein, Distinguished Professor of Pharmaceutical Outcomes & Policy, University of Florida

A panel convened in July 2025 by the Food and Drug Administration sparked controversy by casting doubt about the safety of commonly used antidepressants during pregnancy....